News / Business
Speak with other shareholders about: (OTCBB: SLWF), (OTCBB: NWBO), (Nasdaq: NAVR), and (OTCBB: CLXN) .
----------------------------------------------------------
Chat real-time with other investors about this SLWF news release, by clicking this link: http://www.stockwire.com/SLWF
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=SLWF
Seamless Wi-Fi, Inc. (OTCBB: SLWF) Current Price (0.0007)
LAS VEGAS, NV----Jul 10, 2007 -- Seamless Wi-Fi, Inc. (OTCBB: SLWF) today reported upon several corporate developments, including a recent management trip to China to oversee S-XGen(TM) production and the results from the S-XGen(TM) exhibit at the recent 28th Annual National Educational Computing Conference (NECC).
Seamless Wi-Fi, Inc. (www.slwf.net) is a Las Vegas-based company listed on the OTCBB under the symbol SLWF. Seamless develops and markets cutting-edge internet communications products and services through its three operating subsidiaries: Seamless Skyy-Fi, Inc. (www.skyyfi.com), Seamless Peer 2 Peer, Inc. (www.seamlessp2p.net) and Seamless Internet (www.seamlessinternet.com). Seamless Internet also provides secure hosting services for all Seamless company clientele.
----------------------------------------------------------
Chat real-time with other investors about this NWBO news release, by clicking this link: http://www.stockwire.com/NWBO
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=NWBO
Northwest Biotherapeutics, Inc. (OTCBB: NWBO) Current Price (5.04)
BOTHELL, Wash., July 9 -- Northwest Biotherapeutics, Inc. (OTCBB: NWBO), is pleased to announce that it has received Authorization for Use from the Swiss Institute of Public Health (Bundesamt fur Gesundheit; "BAG") to make DCVax -Brain commercially available for treatment of brain cancer patients in Switzerland. As such, DCVax -Brain is the first commercially available therapeutic vaccine for such cancers. The Company intends to begin making the product available to patients in Q3 2007. Northwest Biotherapeutics, Inc. is a US-based biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, without toxicity, on a cost-effective basis.
----------------------------------------------------------
Chat real-time with other investors about this NAVR news release, by clicking this link: http://www.stockwire.com/NAVR
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=NAVR
Encore Software (Nasdaq: NAVR) Current Price (4.01)
LOS ANGELES, July 10 -- Encore Software, a wholly owned subsidiary of Navarre Corporation (Nasdaq: NAVR) and an interactive publisher of PC software, announced today that it has signed a multi-year agreement with Sony Online Entertainment, a global leader in the online gaming industry, owned by Sony Pictures Digital and Sony Computer Entertainment America, to publish PC software versions of America's favorite game and quiz shows, Wheel of Fortune and Jeopardy!, in North America. Navarre Corporation (Nasdaq: NAVR - News) is a publisher and distributor of physical and digital home entertainment and multimedia products, including PC software, CD audio, DVD and VHS video, video games and accessories. Since its founding in 1983, the company has established distribution relationships with customers across a wide spectrum of retail channels which includes mass merchants, discount, wholesale club, office and electronic superstores, military and e-tailers nationwide. The company currently provides its products to over 19,000 retail and distribution center locations throughout the United States and Canada. Navarre has expanded its business to include the licensing and publishing of home entertainment and multimedia content, primarily through the acquisitions of Encore Software, BCI, and FUNimation. For more information, please visit the company's web site at http://www.navarre.com.
----------------------------------------------------------
Chat real-time with other investors about this CLXN news release, by clicking this link: http://www.stockwire.com/CLXN
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=CLXN
CLX Investment Company, Inc. (OTCBB: CLXN) Current Price (0.012)
TEMECULA, CA---Jul 10, 2007 -- CLX Investment Company, Inc. (OTCBB: CLXN) today announced that the Board of Directors has appointed Steven R. Peacock to the position of consultant chief executive officer for the company. Mr. Peacock, managing director of Javelin Advisory Group, a business development and management firm, will be responsible for executing an acquisition strategy designed to deliver value to the company and its shareholders. CLX Investment Company (www.clxinvestments.com) holds a 31% equity interest in Zonda, Inc. (www.zondaincusa.com). CLX has also invested, and holds a common stock position, in ActionView International, Inc. (www.actionviewinternational.com), a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire: Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
